title: [Late results of the treatment of multiple sclerosis with large doses of Enkorton].
abstract: A group of MS patients treated with large doses of Prednisone (3960 mg over a period of 54 days with initial dose 200 mg per day) was observed during 4 years after the therapy and the results were compared with the control group treated with medium doses of Prednisone (initial dose 60 mg). The difference between two therapeutic groups estimated according to Kurtzke disability scale is statistically not significant. We cannot also conclude, that the large doses of Prednisone decrease the relapse rate. However it should be stressed that in patients treated with megadoses of Prednisone the secondary chronic progressive course of MS, more rarely developed than in cases treated with medium doses.
authors.affiliation: Katedry Neurologii AM w Poznaniu.
authors.forename: M
authors.initials: M
authors.lastname: Wender
authors.forename: E
authors.initials: E
authors.lastname: Tokarz-Kupczyk
authors.forename: O
authors.initials: O
authors.lastname: Mularek
mesh_terms: D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage*; D012008:Recurrence; D013997:Time Factors
chemical_list: D011241:Prednisone
vernacular_title: Odległe wyniki leczenia stwardnienia rozsianego duzymi dawkami Enkortonu.